Subscribe
22 October 2024NewsAmericasMarisa Woutersen

HR, lobbying and business strategy…all in a day’s work for today’s counsel

In-house pharma and biotech lawyers are taking on broader roles, from handling regulatory issues to corporate strategy—and outside counsel can help, finds Marisa Woutersen.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
LSPN Fall: Gilead GC shares top drafting tips
17 October 2024   At LSPN Fall North America, in-house counsel offered guidance on how to nail the perfect patent application. Marisa Woutersen reports.
Americas
LSPN Fall: Why Big Pharma is facing 'a balancing act'
17 October 2024   As the pharma sector grapples with legal and regulatory upheaval, LSPN Fall North America explored the need for companies to reassess their patent strategies. Marisa Woutersen reports.


Editor's picks

Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

Editor's picks

Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024
Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

More on this story

Americas
LSPN Fall: Gilead GC shares top drafting tips
17 October 2024   At LSPN Fall North America, in-house counsel offered guidance on how to nail the perfect patent application. Marisa Woutersen reports.
Americas
LSPN Fall: Why Big Pharma is facing 'a balancing act'
17 October 2024   As the pharma sector grapples with legal and regulatory upheaval, LSPN Fall North America explored the need for companies to reassess their patent strategies. Marisa Woutersen reports.

More on this story

Americas
LSPN Fall: Gilead GC shares top drafting tips
17 October 2024   At LSPN Fall North America, in-house counsel offered guidance on how to nail the perfect patent application. Marisa Woutersen reports.
Americas
LSPN Fall: Why Big Pharma is facing 'a balancing act'
17 October 2024   As the pharma sector grapples with legal and regulatory upheaval, LSPN Fall North America explored the need for companies to reassess their patent strategies. Marisa Woutersen reports.

More features

MSN scores win in battle with Novartis over heart drug generic
President Xi sends message to AIPPI’s World Congress
LSPN Fall: Gilead GC shares top drafting tips
PierFerd adds AI patent partner with ‘dynamic experience’
LSPN Fall: Why Big Pharma is facing 'a balancing act'
GSK fires pair of COVID and RSV lawsuits at Moderna
Novo Nordisk targets Canada’s largest generics maker over diabetes drug
Jones Day hires pharma and high-tech patent litigator to London office